Mark L. Berch

Array ( [id] => 3555286 [patent_doc_number] => 05574156 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-12 [patent_title] => '.beta.-lactams used in preparing taxol' [patent_app_type] => 1 [patent_app_number] => 8/254561 [patent_app_country] => US [patent_app_date] => 1994-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4307 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/574/05574156.pdf [firstpage_image] =>[orig_patent_app_number] => 254561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3571652 [patent_doc_number] => 05538971 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-23 [patent_title] => 'Benzoquinoxalines, pharmaceutical compositions containing them and their use in treating schizophrenia' [patent_app_type] => 1 [patent_app_number] => 8/250989 [patent_app_country] => US [patent_app_date] => 1994-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3806 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/538/05538971.pdf [firstpage_image] =>[orig_patent_app_number] => 250989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3526700 [patent_doc_number] => 05541181 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-30 [patent_title] => 'Compound produced by a strain of micromonospora' [patent_app_type] => 1 [patent_app_number] => 8/249518 [patent_app_country] => US [patent_app_date] => 1994-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8743 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/541/05541181.pdf [firstpage_image] =>[orig_patent_app_number] => 249518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3488909 [patent_doc_number] => 05426189 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-06-20 [patent_title] => 'Dopamine receptor ligands and imaging agents' [patent_app_type] => 1 [patent_app_number] => 8/248313 [patent_app_country] => US [patent_app_date] => 1994-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 9817 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/426/05426189.pdf [firstpage_image] =>[orig_patent_app_number] => 248313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3532075 [patent_doc_number] => 05583225 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-10 [patent_title] => 'Syntheses of acyclic guanine nucleosides' [patent_app_type] => 1 [patent_app_number] => 8/245024 [patent_app_country] => US [patent_app_date] => 1994-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8588 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/583/05583225.pdf [firstpage_image] =>[orig_patent_app_number] => 245024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3546678 [patent_doc_number] => 05554746 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-10 [patent_title] => 'Lactam nucleic acids' [patent_app_type] => 1 [patent_app_number] => 8/243368 [patent_app_country] => US [patent_app_date] => 1994-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16894 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 198 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/554/05554746.pdf [firstpage_image] =>[orig_patent_app_number] => 243368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4316896 [patent_doc_number] => 06242596 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => 'Preparation of betamethyl carbapenem intermediates' [patent_app_type] => 1 [patent_app_number] => 8/241958 [patent_app_country] => US [patent_app_date] => 1994-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3686 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/242/06242596.pdf [firstpage_image] =>[orig_patent_app_number] => 241958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3541824 [patent_doc_number] => 05480987 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-02 [patent_title] => '2-substituted alkyl-3-carboxy carbapenems as antibiotics and a method of producing them' [patent_app_type] => 1 [patent_app_number] => 8/234905 [patent_app_country] => US [patent_app_date] => 1994-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22797 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 694 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/480/05480987.pdf [firstpage_image] =>[orig_patent_app_number] => 234905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3533614 [patent_doc_number] => 05556854 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-17 [patent_title] => 'Pyridopyrimidinediones, processes for their preparation and their use as drugs' [patent_app_type] => 1 [patent_app_number] => 8/230811 [patent_app_country] => US [patent_app_date] => 1994-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12129 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 329 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/556/05556854.pdf [firstpage_image] =>[orig_patent_app_number] => 230811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3113084 [patent_doc_number] => 05395836 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-03-07 [patent_title] => '8-tricycloalkyl xanthine derivatives' [patent_app_type] => 1 [patent_app_number] => 8/222938 [patent_app_country] => US [patent_app_date] => 1994-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13656 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/395/05395836.pdf [firstpage_image] =>[orig_patent_app_number] => 222938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3715948 [patent_doc_number] => 05616586 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-01 [patent_title] => 'Tricyclic quinoxalinediones' [patent_app_type] => 1 [patent_app_number] => 8/211314 [patent_app_country] => US [patent_app_date] => 1994-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43138 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1377 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/616/05616586.pdf [firstpage_image] =>[orig_patent_app_number] => 211314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3593838 [patent_doc_number] => 05488110 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-30 [patent_title] => 'Highly water soluble bis-naphthalimides useful as anticancer agents' [patent_app_type] => 1 [patent_app_number] => 8/219596 [patent_app_country] => US [patent_app_date] => 1994-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5056 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/488/05488110.pdf [firstpage_image] =>[orig_patent_app_number] => 219596 [rel_patent_id] =>[rel_patent_doc_number] =>)